Skip to content
10-Q

Quarterly Report

VitaNova Life Sciences Corporation VNOV

0001683168-25-009163

← back to feed
Filed
Dec 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Dec 15, 2025 25.01M sh
Shares Diluted Q2 2026 · Oct 31, 2025 25.01M sh
Shares Diluted Q2 2026 · Oct 31, 2025 25.01M sh
Shares Diluted Q2 2026 · Oct 31, 2024 25.01M sh
Shares Diluted Q2 2026 · Oct 31, 2024 25.01M sh
Operating Cash Flow Q2 2026 · Oct 31, 2025 $476.47K
Operating Cash Flow Q2 2026 · Oct 31, 2024 −$495.24K
Stockholders Equity Q2 2026 · Oct 31, 2025 $1.9M
Stockholders Equity Q2 2026 · Jul 31, 2025 $1.86M
Stockholders Equity Q2 2026 · Apr 30, 2025 $1.91M
Stockholders Equity Q2 2026 · Oct 31, 2024 $1.03M
Stockholders Equity Q2 2026 · Jul 31, 2024 $1M
Stockholders Equity Q2 2026 · Apr 30, 2024 $1.06M
Current Liabilities Q2 2026 · Oct 31, 2025 $438.05K
Current Liabilities Q2 2026 · Apr 30, 2025 $347.57K
Total Liabilities Q2 2026 · Oct 31, 2025 $438.05K
Total Liabilities Q2 2026 · Apr 30, 2025 $347.57K
Current Assets Q2 2026 · Oct 31, 2025 $2.34M
Current Assets Q2 2026 · Apr 30, 2025 $2.26M
Total Assets Q2 2026 · Oct 31, 2025 $2.34M
Total Assets Q2 2026 · Apr 30, 2025 $2.26M
Eps Diluted Q2 2026 · Oct 31, 2025 $0.00
Eps Diluted Q2 2026 · Oct 31, 2025 $0.00
Eps Diluted Q2 2026 · Oct 31, 2024 $0.00
Eps Diluted Q2 2026 · Oct 31, 2024 $0.00
Eps Basic Q2 2026 · Oct 31, 2025 $0.00
Eps Basic Q2 2026 · Oct 31, 2025 $0.00
Eps Basic Q2 2026 · Oct 31, 2024 $0.00
Eps Basic Q2 2026 · Oct 31, 2024 $0.00
Sga Expense Q2 2026 · Oct 31, 2025 $119.44K
Sga Expense Q2 2026 · Oct 31, 2025 $185.74K
Sga Expense Q2 2026 · Oct 31, 2024 $40.11K
Sga Expense Q2 2026 · Oct 31, 2024 $97.68K
Net Income Q2 2026 · Oct 31, 2025 $35.81K
Net Income Q2 2026 · Oct 31, 2025 −$10.49K
Net Income Q2 2026 · Jul 31, 2025 −$46.3K
Net Income Q2 2026 · Oct 31, 2024 $32.65K
Net Income Q2 2026 · Oct 31, 2024 −$22.56K
Net Income Q2 2026 · Jul 31, 2024 −$55.21K
Operating Income Q2 2026 · Oct 31, 2025 $99.17K
Operating Income Q2 2026 · Oct 31, 2025 $66.73K
Operating Income Q2 2026 · Oct 31, 2024 $62.6K
Operating Income Q2 2026 · Oct 31, 2024 $17.19K
Gross Profit Q2 2026 · Oct 31, 2025 $260.8K
Gross Profit Q2 2026 · Oct 31, 2025 $329.58K
Gross Profit Q2 2026 · Oct 31, 2024 $155.83K
Gross Profit Q2 2026 · Oct 31, 2024 $229.01K
Cost Of Revenue Q2 2026 · Oct 31, 2025 $166.31K
Cost Of Revenue Q2 2026 · Oct 31, 2025 $201.43K
Cost Of Revenue Q2 2026 · Oct 31, 2024 $136.28K
Cost Of Revenue Q2 2026 · Oct 31, 2024 $171.59K
Revenue Q2 2026 · Oct 31, 2025 $427.12K
Revenue Q2 2026 · Oct 31, 2025 $531.01K
Revenue Q2 2026 · Oct 31, 2024 $292.12K
Revenue Q2 2026 · Oct 31, 2024 $400.6K